![Drew Pardoll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Drew Pardoll
Founder at
Potenza Therapeutics, Inc.
Profile
Drew M.
Pardoll was the founder of Amplimmune, Inc. (founded 2007) where the title held was Director from 2009 to 2011.
Dr. Pardoll is the founder of Jounce Therapeutics, Inc. (founded 2013).
Dr. Pardoll is the founder of TRex Bio, Inc. (founded 2018).
Dr. Pardoll is the founder of Potenza Therapeutics, Inc. (founded 2014) and holds the title Member-Scientific Advisory Board since 2014.
Dr. Pardoll is also the founder of Clasp Therapeutics, Inc.,Tizona Therapeutics, Inc.,Enara Bio Ltd...
Dr. Pardoll is currently Director at DNAtrix, Inc., Director at The Sidney Kimmel Comprehensive Cancer Center since 2009, Director at Dracen Pharmaceuticals, Inc., Professor at The Johns Hopkins University, and Venture Partner at Catalio Capital Management LP.
Formerly, Dr. Pardoll was on the Scientific Advisory Board at Five Prime Therapeutics, Inc. Dr. Pardoll earned a doctorate from The Johns Hopkins University in 1982.
Drew Pardoll active positions
| Companies | Position | Start |
|---|---|---|
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Sidney Kimmel Comprehensive Cancer Center
 The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Director/Board Member | 2009-08-27 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Founder | 2013-12-31 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Director/Board Member | - |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director/Board Member | - |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Founder | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Former positions of Drew Pardoll
| Companies | Position | End |
|---|---|---|
ManaT Bio, Inc.
 ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Founder | - |
Trex Bio, Inc.
 Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Founder | - |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Drew Pardoll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Sidney Kimmel Comprehensive Cancer Center
The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
ManaT Bio, Inc.
ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Health Technology |
Enara Bio Ltd.
 Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Health Technology |
- Stock Market
- Insiders
- Drew Pardoll
